Subacute sclerosing panencephalitis

Postgraduate Medical Journal

Volumn 78, Issue 916, 2002, Pages 63-70

  Garg, Ravindra Kumar ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMANTADINE; BETA INTERFERON; CIMETIDINE; CORTICOSTEROID; IMMUNOGLOBULIN; METHISOPRINOL; RIBAVIRIN;

BRAIN BIOPSY; CLINICAL FEATURE; DISEASE COURSE; ELECTROENCEPHALOGRAM; HISTOPATHOLOGY; HUMAN; MEASLES VIRUS; REVIEW; SUBACUTE SCLEROSING PANENCEPHALITIS;

ANTIVIRAL AGENTS; BRAIN; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEASLES; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; SSPE VIRUS; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS LATENCY;

EID: 0036157934     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.916.63     Document Type: Review

References (88)

1. Encephalitis and encephalomyelitis in England and Wales during last decade
2. Cellular inclusions in cerebral lesions of epidemic encephalitis
3. Uber einheimische panencephalomyelitis vom charakter der encephalitis Japonica
4. Une leocoencephalite sclerosante subaigue
5. Sur uncas d'encephalite subalguea inclusions. Etude anatomoclinique et ultra structurale
6. Subacute sclerosing panencephalitis: Isolation of measles virus from a brain biopsy
7. Subaute sclerosing panencephalitis and other paramyxovirus infections
8. Epidemiology of subacute sclerosing panencephalitis (SSPE): Report of the SSPE registry
9. High incidence of subacute sclerasing panencephalitis in South India
10. Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya
11. Subacute sclerosing panencephalitis (SSPE): Early diagnosis, prognostic factors and natural history
12. Risk factors in subacute sclerosing panencephalitis: A case-control study
13. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989
14. Environmental risk factors for subacute sclerosing panencephalitis (SSPE)
15. Epidemiology of subacute sclerosing panencephalitis
16. Risk factors in subacute sclerosing panencephaltis: Age-and sex-dependent host reactions or intensive exposure
17. Changing character of subacute sclerosing panencephalitis in the United States
18. Clonal expansion of hypermutated measles virus in a SSPE brain
19. Cerebral endothelial cell infection by measles virus in subacute sclerosing panencephalitis: Ultrastructural and in situ hybridization evidence
20. Measles virus infection of cells in perivascular infiltrates in the brain in subacute sclerosing panencephalitis; confirmation by non-radioactive in situ hybridization, immunocytochemistry and electron microscopy
21. Clinical spectrum of measles
22. Case records of the Massachusetts General Hospital, case 25-1986
23. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium farmation, or extracellular virus production
24. Subacute sclerosis panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: Implication for viral persistence
25. Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line
26. Mutated and hypermutated genes of persistent measles virus which caused lethal human brain diseases
27. Functional and nonfunctional measles virus matrix genes from lethal human brain infection
28. Functional analysis of matrix proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocapsid binding
29. Defective measles virus in human subacute sclerosing panencephalitis brain
30. Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis
31. 46 molecule is a receptor for measles virus (Edmonston strain)
32. Cell fusion by the envelope glycoproteins of persistent measles viruses, which caused lethal human brain disease
33. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus
34. Measles viruses with altered envelop protein cytoplasmic tails gain cell fusion competence
35. Case records of the Massachusetts General Hospital: Case 15-1998
36. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell
37. Post-mortem detection of measles virus in non-neural tissues in subacute sclerosing panencephalitis
38. Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients
39. Apoptosis in measles virus-infected human central nervous system tissues
40. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination
41. Numerous glial fibrillary tangles in oligodendroglia in cases of subacute sclerosing panencephalitis with neurofibrillary tangles
42. Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: A combined in situ hybridization and immunocytochemical investigation
43. Subacute sclerosing panencephalitis: Correlation of clinical, neurophysiologic and neurophathologic findings
44. Immunocytochemical analysis of the cellular infiltrate in brain lesions in subacute sclerosing panencephalitis
45. Measles virus in the brain
46. Detection of measles virus mRNA from autopsied human tissues
47. Subacute sclerosing panencephalitis
48. Ophthalmoscopic findings in subacute sclerosing panencephalitis
49. Atypical chorioretinitis as the very first presentation of subacute sclerosing panencephalitis
50. Subacute sclerosing panencephalitis manifesting as viral retinitis: Clinical and histopathologic findings
51. The voriable natural history of subacute sclerosing panencephalitis: A study of 118 cases from the Middle East
52. Subacute sclerosing panencephalitis with atypical onset: Clinical, computed tomography and magnetic resonance imaging correlations
53. Quantification of measles virus specific immunoglobulins in serum, CSF and brain extract from patients with subacute sclerosing panencephalitis
54. Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE
55. Quantification of virus specific antibodies in cerebrospinal fluid and serum: Sensitive and specific detection of antibody synthesis in brain
56. Immune response in subacute sclerosing panencephalitis
57. Identification of different measles virus specific antibodies in serum and cerebrospinal fluid from patients with subacute sclerosing panencephalitis and multiple sclerosis
58. Different virus antibodies in serum and cerebro-spinal fluid of patients suffering from subacute sclerosing panencephalitis
59. Serodiagnosis of subacute sclerosing panencephalitis by enzyme linked immunosorbent assay
60. Clinical significance of periodic EEG patterns
61. Subacute sclerosing panencephalitis. Changes on CT scan during acute relapse
62. MRI in subacute sclerosing panencephalitis
63. MRI findings in subacute sclerosing panencephalitis
64. Subacute sclerosing panencephalitis: Evaluation with CT and MR
65. Adult-onset subacute sclerosing panencephalitis: Case reports and review of literature
66. α-Interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis
67. Fulminant subacute sclerosing panencephalitis in association with pregnancy
68. Healthy infant delivered by a mother with subacute sclerosing panencephalitis during pregnancy
69. Fulminating subacute sclerosing panencephalitis: Case report and literature review
70. Subacute sclerosing panencephalitis: CT and MR imaging in a rapidly progressive case
71. Acute fulminant SSPE. Clinical and EEG features
72. A 35-year old bricklayer with hemimyoclonic jerks
73. Substantial spontenous long-term remission in subacute sclerosing panencephalitis (SSPE)
74. Inosine pranobex: A preliminary review of its pharmacodynamic and pharmakinetic properties and therapeutic efficacy
75. Inosiplex therapy in subacute sclerosing panencephalitis
76. Inosiplex treatment in 18 patients with SSPE. A controlled study
77. Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis
78. Subacute sclerosing panencephalitis remission after treatment with interferon
79. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis
80. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-inteferon
81. Intraventricular alpha-inteferon in subacute sclerosing panencephalitis
82. Toxic effect of intraventricular interferon-alpha in subacute sclerosing panencephalitis
83. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis
84. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis
85. Review of 32 cases of subacute sclerosing panencephalitis: Effect of amantadine on natural course of disease
86. Cimetidine as an immuno-modulator in subacute sclerosing panencephalitis. A double blind placebo-controlled study
87. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis
88. Intravenous gamma-globulin treatment in a patient with subacute sclerosing panencephalitis